Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Biesman

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Aesthetic Surgery Journal|June 24, 2024
Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar LinesSachin M Shridharani, Amir Moradi, Lisa Donofrio, et al.
Aesthetic Surgery Journal|April 17, 2025
Subject-Reported Outcomes for Glabellar Line Improvement and Satisfaction With the Relabotulinumtoxina Ready-to-Use Liquid Formulation: Data From the Phase 3 READY-1 TrialMichael H Gold, Lisa Donofrio, Sachin Shridharani, et al.
Aesthetic Surgery Journal|June 22, 2023
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat ReductionSachin M Shridharani, Steven Dayan, Brian Biesman, et al.
Journal of Cosmetic Dermatology|August 20, 2024
Deliberations of the Safety Task Force: Risk factors and treatment of adverse events associated with aesthetic injectablesAndreas Nikolis, Joel L Cohen, Kaitlyn M Enright, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Aesthetic Surgery Journal|June 24, 2024
Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar LinesSachin M Shridharani, Amir Moradi, Lisa Donofrio, et al.
Aesthetic Surgery Journal|April 17, 2025
Subject-Reported Outcomes for Glabellar Line Improvement and Satisfaction With the Relabotulinumtoxina Ready-to-Use Liquid Formulation: Data From the Phase 3 READY-1 TrialMichael H Gold, Lisa Donofrio, Sachin Shridharani, et al.
Aesthetic Surgery Journal|June 22, 2023
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat ReductionSachin M Shridharani, Steven Dayan, Brian Biesman, et al.
Journal of Cosmetic Dermatology|August 20, 2024
Deliberations of the Safety Task Force: Risk factors and treatment of adverse events associated with aesthetic injectablesAndreas Nikolis, Joel L Cohen, Kaitlyn M Enright, et al.
Pageof 3